How does tumor stage affect your choice of adjuvant chemotherapy in pancreatic cancer?

Would you consider gem+Abraxane to avoid FOLFIRINOX toxicity in a small, node-negative tumor?

Answer from: Medical Oncologist at Academic Institution

I have moved my practice for resectable PDAC (and certainly borderline resectable tumors) almost entirely to neoadjuvant therapy. The SWOG S1505 study (see links below) has shown that either gem/Abraxane or FOLFIRINOX is appropriate. In the adjuvant setting, there is better data for FFX and gem/cis ...

Comments

Medical Oncologist at Joliet Oncology Hematology Associates
I agree NAC should be given for pancreatic ca, how...

Please select the option that best describes you:

How does tumor stage affect your choice of adjuvant chemotherapy in pancreatic cancer?

Related Questions